Skip to content

Tycheseal™

by Beijing Percutek Therapeutics Inc. China EUDAMED

Ref PABF2614110Model PABF

EMDN P070102010102

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-06957485010083 Basic UDI-DIDate7 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Tycheseal™ Abdominal aortic stent graft system
Model / Reference
PABF, PABF2614110
Primary DI / UDI-DI
06957485010083
Basic UDI-DI
B-06957485010083
EMDN Code
P070102010102 Dacron vascular prostheses, straight, woven
Device Class
Class III
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
CN-MF-000013927
Authorised representative
MedNet EC-REP GmbH DE-AR-000000002

Other devices from Beijing Percutek Therapeutics Inc.

See all devices from Beijing Percutek Therapeutics Inc. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
Other properties (11)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 3c9a58f7-b6c8-4561-9463-3e684673ebcd 61 fields · synced 22 Oct 2026